Fundamentals data is not available for this company.
No recent information was found.
| Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
| Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
| Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
| Currency | US Dollars |
| Share Price | $ 28.26 |
| Change Today | $ 0.28 |
| % Change | 1.00 % |
| 52 Week High | $28.63 |
| 52 Week Low | $27.56 |
| Volume | 1,323,285 |
| Shares Issued | 156.88m |
| Market Cap | $4,433.50m |
| RiskGrade | 248 |
| Time | Volume / Share Price |
| 16:00 | 179,272 @ $28.26 |
| 15:59 | 100 @ $28.26 |
| 15:59 | 124 @ $28.25 |
| 15:59 | 199 @ $28.24 |
| 15:59 | 100 @ $28.25 |
You are here: research